BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 25474456)

  • 1. What is your diagnosis? Cutaneous B-cell lymphoma.
    Carlson SW; Aneja S; Honda K; Cooper KD
    Cutis; 2014 Nov; 94(5):217, quiz 249-51. PubMed ID: 25474456
    [No Abstract]   [Full Text] [Related]  

  • 2. Education and Imaging. Gastroenterology: mesenteric lymphoma with chylous ascites.
    Arasawa S; Nakase H; Minami N
    J Gastroenterol Hepatol; 2014 Aug; 29(8):1570. PubMed ID: 25073631
    [No Abstract]   [Full Text] [Related]  

  • 3. Richter's transformation of chronic lymphocytic leukemia.
    Giardino AA; O'Regan K; Jagannathan JP; Elco C; Ramaiya N; Lacasce A
    J Clin Oncol; 2011 Apr; 29(10):e274-6. PubMed ID: 21220587
    [No Abstract]   [Full Text] [Related]  

  • 4. Patient with high-grade fever, night sweats, and hepatosplenomegaly.
    Müldür E; Chott A; Mirzaei S; Zojer N; Ludwig H
    J Clin Oncol; 2011 Apr; 29(10):e254-6. PubMed ID: 21220615
    [No Abstract]   [Full Text] [Related]  

  • 5. Primary cutaneous intravascular large B-cell lymphoma treated with combination chemotherapy and complicated by rituximab-induced interstitial lung disease.
    Park GH; Kim CH; Chung WK; Won CH; Chang SE; Lee MW; Choi JH; Moon KC
    Acta Derm Venereol; 2010 May; 90(3):296-8. PubMed ID: 20526551
    [No Abstract]   [Full Text] [Related]  

  • 6. Front-line management of diffuse large B cell lymphoma.
    Cabanillas F
    Curr Opin Oncol; 2010 Nov; 22(6):642-5. PubMed ID: 20811278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An 82-year-old woman with left upper lobe atelectasis. Diffuse large B-cell lymphoma.
    Seeram V; Shujaat A; Jones L; Bajwa A
    Chest; 2012 Dec; 142(6):1669-1674. PubMed ID: 23208341
    [No Abstract]   [Full Text] [Related]  

  • 8. [Primary diffuse large B-cell lymphoma of the uterine cervix successfully treated with rituximabplus cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy-a case report].
    Hashimoto A; Fujimi A; Kanisawa Y; Matsuno T; Okuda T; Minami S; Doi T; Ishikawa K; Uemura N; Jyomen Y; Tomaru U
    Gan To Kagaku Ryoho; 2013 Dec; 40(13):2589-92. PubMed ID: 24335377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An unresectable Klatskin's tumor?
    Hartl J; Werner T; Schramm C
    Gastroenterology; 2014 Jun; 146(7):e3-4. PubMed ID: 24780210
    [No Abstract]   [Full Text] [Related]  

  • 10. Activity and safety of dose-adjusted infusional cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy with rituximab in very elderly patients with poor-prognostic untreated diffuse large B-cell non-Hodgkin lymphoma.
    Fabbri A; Gozzetti A; Rigacci L
    Cancer; 2011 Aug; 117(15):3530; author reply 3531. PubMed ID: 21287541
    [No Abstract]   [Full Text] [Related]  

  • 11. Addictive response of primary cutaneous diffuse large B cell lymphoma leg type to low-dose ibrutinib.
    Pang A; Au-Yeung R; Leung RYY; Kwong YL
    Ann Hematol; 2019 Oct; 98(10):2433-2436. PubMed ID: 31446456
    [No Abstract]   [Full Text] [Related]  

  • 12. Two cases of concomitant diffuse large B-cell lymphoma and myelodysplastic syndrome.
    Dozzo M; Zaja F; Volpetti S; Chiozzotto M; Puglisi S; Mazzucco M; Perali G; Fanin R
    Am J Hematol; 2014 Oct; 89(10):1011-3. PubMed ID: 24912474
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical features and treatment outcomes of intravascular large B-cell lymphoma: a single-center experience in Korea.
    Hong JY; Kim HJ; Ko YH; Choi JY; Jung CW; Kim SJ; Kim WS
    Acta Haematol; 2014; 131(1):18-27. PubMed ID: 24021554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activity and safety of dose-adjusted infusional cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy with rituximab in very elderly patients with poor-prognostic untreated diffuse large B-cell non-Hodgkin lymphoma.
    Musolino A; Boggiani D; Panebianco M; Vasini G; Salvagni S; Franciosi V; Ardizzoni A
    Cancer; 2011 Mar; 117(5):964-73. PubMed ID: 20960528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diffuse large B-cell lymphoma with a bulky mass in the cranial vault.
    Kanaya M; Endo T; Hashimoto D; Endo S; Takemura R; Okada K; Hatanaka KC; Matsuno Y; Teshima T
    Int J Hematol; 2017 Aug; 106(2):147-148. PubMed ID: 28390034
    [No Abstract]   [Full Text] [Related]  

  • 16. [Prognostic impact of bone marrow involvement (BMI) and therapies in diffuse large B cell lymphoma].
    Yi SH; Xu Y; Zou DH; An G; Zhao YZ; Qi JY; Qiu LG
    Zhonghua Xue Ye Xue Za Zhi; 2009 May; 30(5):307-12. PubMed ID: 19799125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Occurrence of sarcoidosis after chemotherapy for non-Hodgkin lymphoma.
    Cho H; Yoon DH; Kim JH; Ko YB; Kwon BS; Song IH; Suh C
    Korean J Intern Med; 2016 May; 31(3):605-7. PubMed ID: 26968186
    [No Abstract]   [Full Text] [Related]  

  • 18. Vanishing right ventricular outflow obstruction: an unusual presentation of mediastinal lymphoma.
    Kolhari VB; Nagesh CM; Singh Y; Manjunath CN
    Eur Heart J; 2013 Jul; 34(25):1784. PubMed ID: 23641012
    [No Abstract]   [Full Text] [Related]  

  • 19. Rituximab CHOP for successful management of diffuse large B-cell lymphoma of the ovary.
    Ahbeddou N; Fetohi M; Khanoussi BE; Errihani H
    Arch Gynecol Obstet; 2011 May; 283(5):1173-4. PubMed ID: 20957380
    [No Abstract]   [Full Text] [Related]  

  • 20. [Interest of an intensive chemotherapy for intravascular large B cell lymphoma].
    Baldolli A; Chuffart M; Geffray L; Verneuil L; Reman O
    Bull Cancer; 2013 Apr; 100(4):317-21. PubMed ID: 23587663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.